Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion

Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion - a Pilot Study

To assess the safety and feasibility of the IKORUS device in critically ill patients and to gather exploratory data on haemodynamic coherence

Inclusion Criteria:

• Within 24 h of ICU admission
• Predicted length of ICU stay at least 5 days
• Receiving >0.1 mcg/kg/min of noradrenaline at time of study enrolment

Exclusion Criteria:

• Palliative treatment intent
• Contra indication to urethral catheterisation or complication during previous urethral catheter insertion
• Contraindication to fluid or vasopressor challenges in the opinion of the attending clinician